Back
Kymera Therapeutics Stock Predictions
Sponsored
KYMR
Sponsored
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.
Buy
71
KYMR
Kymera Therapeutics
Last Price:
46.27
Seasonality Move:
65.72%
7 Day Trial
ALL ACCESS PASS
$
7
7 Proven Winners to Buy and Hold Forever
More Details here...Kymera Therapeutics Stock Forecast
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 54.1% based on the past 4 years of stock performance.
- Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Kymera Therapeutics Stock Undervalued?
The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal. - KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Kymera Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 54.1% based on the past 4 years of stock performance.
Kymera Therapeutics Stock Rating
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics overpriced?
- Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Kymera Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com
52-Week Data
52-Week High:
53.27
52-Week Low:
9.60
Prediction Charts
Market Cap:
3.03B
Price in USD:
49.02
Volume:
339.81K
Beta:
2.19
Technical Analysis
SMA50:
46.11
SMA100:
41.39
SMA200:
38.62
52-Wk Change:
286.9%
Stock Predictions
-
Is Kymera Therapeutics stock public?
Yes, Kymera Therapeutics is a publicly traded company. -
What is the Kymera Therapeutics stock quote today?
The Kymera Therapeutics stock price is 49.02 USD today. -
How to buy Kymera Therapeutics stock online?
You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-27 | 49.84 | 48.69 | 50.60 | 48.33 |
Sep-30 | 48.38 | 47.27 | 49.66 | 46.78 |
Oct-1 | 46.96 | 46.57 | 47.48 | 46.02 |
Oct-2 | 45.93 | 45.00 | 46.25 | 44.75 |
Oct-3 | 44.75 | 43.43 | 45.32 | 43.00 |
Oct-4 | 44.07 | 43.06 | 44.19 | 42.71 |
Oct-7 | 42.80 | 42.21 | 42.94 | 41.61 |
Oct-8 | 42.50 | 42.97 | 43.90 | 42.41 |
Oct-9 | 43.25 | 43.34 | 43.44 | 42.00 |
Oct-10 | 42.61 | 43.21 | 43.93 | 42.36 |
Oct-11 | 43.18 | 45.02 | 45.29 | 43.18 |
Oct-14 | 44.74 | 46.05 | 46.50 | 44.74 |
Oct-15 | 46.43 | 44.80 | 46.43 | 44.35 |
Oct-16 | 45.10 | 49.02 | 49.17 | 44.66 |
Kymera Therapeutics Earnings
Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kymera Therapeutics Forecast Revenue Growth
Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.